{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:12:40Z","timestamp":1778274760325,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007144","name":"University of Houston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007144","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omton.2026.201125","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:19:46Z","timestamp":1767802786000},"page":"201125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rhabdoid tumors as a novel target for PSMA-directed CAR T cell therapy"],"prefix":"10.1016","volume":"34","author":[{"given":"Aroshi","family":"Mitra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacky","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengtai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrita","family":"Barua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajkumar","family":"Venkatramani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moonsoo M.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4257-8404","authenticated-orcid":false,"given":"Qin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201125_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1615\/CritRevOncog.2015013566","article-title":"Biology and Treatment of Rhabdoid Tumor","volume":"20","author":"Geller","year":"2015","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.omton.2026.201125_bib2","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/foc.2006.20.1.12","article-title":"Molecular genetics of atypical teratoid\/rhabdoid tumor","volume":"20","author":"Biegel","year":"2006","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.omton.2026.201125_bib3","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/s41379-022-01144-1","article-title":"Adult rhabdoid tumors-a riddle inside an enigma?","volume":"35","author":"Johann","year":"2022","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.omton.2026.201125_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccell.2016.02.001","article-title":"Atypical Teratoid\/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes","volume":"29","author":"Johann","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2026.201125_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00401-018-1814-2","article-title":"Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous","volume":"136","author":"Pinto","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omton.2026.201125_bib6","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1016\/j.wneu.2023.10.089","article-title":"Management of Atypical Teratoid\/Rhabdoid Tumors in the Pediatric Population: A Systematic Review and Meta-Analysis","volume":"181","author":"Gupta","year":"2024","journal-title":"World Neurosurg."},{"key":"10.1016\/j.omton.2026.201125_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/28212","article-title":"Truncating mutations of hSNF5\/INI1 in aggressive paediatric cancer","volume":"394","author":"Versteege","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201125_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semcancer.2019.12.017","article-title":"Translational genomics of malignant rhabdoid tumours: Current impact and future possibilities","volume":"61","author":"Finetti","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.omton.2026.201125_bib9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jcb.10661","article-title":"Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer","volume":"91","author":"Ghosh","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.omton.2026.201125_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jcb.20244","article-title":"Correspondence re: Ghosh A and Heston WDW. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer","volume":"93","author":"Cardillo","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.omton.2026.201125_bib11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1470-2045(18)30198-0","article-title":"[(177)Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study","volume":"19","author":"Hofman","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omton.2026.201125_bib12","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201125_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.30699\/ijp.13.1.45","article-title":"Expression of Prostate-Specific Membrane Antigen (PSMA) in Brain Glioma and its Correlation with Tumor Grade","volume":"13","author":"Saffar","year":"2018","journal-title":"Iran. J. Pathol."},{"key":"10.1016\/j.omton.2026.201125_bib14","first-page":"919","article-title":"PSMA expression on neovasculature of solid tumors","volume":"35","author":"Van de Wiele","year":"2020","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.omton.2026.201125_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0090-4295(00)01094-3","article-title":"Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen","volume":"57","author":"Chang","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.omton.2026.201125_bib16","article-title":"Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2026.201125_bib17","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1097-0142(19930501)71:9<2862::AID-CNCR2820710930>3.0.CO;2-D","article-title":"Malignant rhabdoid tumor. A study with two established cell lines","volume":"71","author":"Ota","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.omton.2026.201125_bib18","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1038\/sj.onc.1203168","article-title":"Alteration of hSNF5\/INI1\/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors","volume":"18","author":"DeCristofaro","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2026.201125_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gcc.10052","article-title":"Aberrations of the hSNF5\/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid\/rhabdoid tumors in pediatric solid tumors","volume":"34","author":"Uno","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.omton.2026.201125_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.864518","article-title":"Atypical Teratoid\/Rhabdoid Tumor of the Central Nervous System in Children: Case Reports and Literature Review","volume":"9","author":"Guo","year":"2022","journal-title":"Front. Surg."},{"key":"10.1016\/j.omton.2026.201125_bib21","article-title":"GATA2 up-regulation restores androgen receptor chromatin association and advances darolutamide resistance in prostate cancer","volume":"12","author":"Zhou","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.omton.2026.201125_bib22","series-title":"Psma-targeted immunotherapies for cancers. US patent application 20230381316","author":"He","year":"2023"},{"key":"10.1016\/j.omton.2026.201125_bib23","article-title":"PSMA-targeted PET imaging for brain metastases from non-prostatic solid tumors: a systematic review","volume":"15","author":"Dall' Armellina","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2026.201125_bib24","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.neuroscience.2006.10.022","article-title":"Expression of glutamate carboxypeptidase II in human brain","volume":"144","author":"Sacha","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.omton.2026.201125_bib25","doi-asserted-by":"crossref","first-page":"14498","DOI":"10.1016\/S0021-9258(18)47823-4","article-title":"Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain","volume":"262","author":"Robinson","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2026.201125_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101722","article-title":"N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications","volume":"184","author":"Neale","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.omton.2026.201125_bib27","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/acschemneuro.3c00494","article-title":"Parallel Metabolomics and Lipidomics of a PSMA\/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition","volume":"15","author":"Sedlak","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.omton.2026.201125_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1535-6108(02)00185-X","article-title":"Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5","volume":"2","author":"Roberts","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2026.201125_bib29","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/s41467-022-29152-4","article-title":"Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumors","volume":"13","author":"Graf","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201125_bib30","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/nm.2251","article-title":"Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway","volume":"16","author":"Jagani","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201125_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ccell.2018.11.014","article-title":"Comprehensive Analysis of Chromatin States in Atypical Teratoid\/Rhabdoid Tumor Identifies Diverging Roles for SWI\/SNF and Polycomb in Gene Regulation","volume":"35","author":"Erkek","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2026.201125_bib32","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/PAS.0b013e318224d2cd","article-title":"Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins","volume":"35","author":"Venneti","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.omton.2026.201125_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010752","article-title":"Galaxy Training: A powerful framework for teaching","volume":"19","author":"Hiltemann","year":"2023","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.omton.2026.201125_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:25:48Z","timestamp":1778271948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926000019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2950329926000019"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201125","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rhabdoid tumors as a novel target for PSMA-directed CAR T cell therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201125"}}